Adventist Health System and B. Braun Sign Contract For IV Systems and Infusion

Article

Bethlehem, PA -- B. Braun Medical Inc. announced that it had entered into an agreement with Adventist Health System, a hospital and home-health care leader, for its full-line of infusion products. Adventist, which operates more than 80 institutions across 10 states, is among the largest 200 members of the Premier, Inc. hospital and healthcare alliance. Premier, with over 1,500 hospitals and health systems members, has signed a five-year full-line infusion contract with B. Braun.

As a result of this new agreement, Adventist Health System institutions now gain access to B. Braun IV therapy products, including safety-engineered products like the Outlook® Safety Infusion System, Introcan Safety® IV Catheter, ULTRASITE® Needle-Free IV System, SureCan®, Excel® and PAB® PVC Free/DEHP-Free IV Containers, and the DUPLEX® Drug Delivery System.

B. Braun needle-free passive safety systems, non-PVC containers and the Outlook wireless infusion system will help Adventist meet immediate and long-term goals of medical-error reduction, employee injury prevention and enhanced patient care, said Tim Richards, senior vice president of marketing at B. Braun Medical Inc.

Adventist Health System is building state-of-the-art health facilities with innovations such as wireless data transmission to help achieve excellence in quality care and services, said Celeste West, corporate director of supply chain, Adventist Health System. B. Braun medication-management Outlook infusion pumps, DEHP-free IV containers, and the option for Introcan Safety IV Catheters enhance our leadership in patient safety and environmental protection, enabling us to maximize investments in facility development and advanced health technology.

Source: Adventist Health System and B. Braun

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.